← SynDRA
ABACAVIR
SynDRA canonical compound SYN0005878 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | nucleoside reverse transcriptase inhibitor |
| Indication | human immunodeficiency virus (HIV-1) |
| Disease area | infectious disease |
All known targets
- HIV RT
- gag-pol
- pol
- reverse transcriptas
Mechanisms of action (all sources)
- nucleoside reverse transcriptase inhibitor
- Inhibitor
- pol INHIBITOR
Drug classes
- Nucleoside Reverse Transcriptase Inhibitors
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Anti-HIV Agents
- Anti-Infective Agents
- Anti-Retroviral Agents
- Antiviral Agents
- Enzyme Inhibitors
- Nucleic Acid Synthesis Inhibitors
- Reverse Transcriptase Inhibitors
- Cytochrome P450 1A1 Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- 1592U89
- abacavir sulfate
- ziagen
- abacavir succinate
- Avacavir
- Epzicom
- NSC-742406
- Ziagen
- Trizivir
- Abacavir [INN]
- Abacavir (INN)
- Ziagen (TN)
- Ziagen (TM)(*Succinate salt*)
- [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol
- {(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol
- (+/-)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
- (+/-)-Abacavir
- (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
- ABC
- NSC 742406
- WR2TIP26VS
- CHEBI:421707
- abacavirum
- (+)-abacavir sulfate
- RefChem:551202
- (1R,4S)-abacavir sulfate
- J05AF06
- DTXCID601478426
- MFCD00903850
- Abacavir (1.0 mg/mL in Methanol)
- Abacavir [INN:BAN]
- UNII-WR2TIP26VS
- NSC742406
- NCGC00164560-01
- Abacavir (Standard)
- ABACAVIR [MI]
- ABACAVIR [VANDF]
- AVACAVIR [VANDF]
Reported adverse events
- Hypersensitivity
- Lactic acidosis
- Hepatomegaly
- Lactic acid
- Hepatitis
- Hepatitis B
- Acidosis
- P
- Se
- Myopathy
- DIC
- UTI
Look up ABACAVIR in the interactive SynDRA portal →